The Reorganization of a Psychiatric Unit During COVID-19: A Reflection for Psychiatric Hospital Design.

COVID-19 evidence-based design mental healthcare psychiatry therapeutic landscapes transdisciplinary study

Journal

HERD
ISSN: 2167-5112
Titre abrégé: HERD
Pays: United States
ID NLM: 101537529

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 14 5 2022
medline: 28 9 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

The COVID-19 pandemic has impacted healthcare systems worldwide. Although this disease has primarily impacted general medicine intensive care units, other areas of healthcare including psychiatry were modified in response to corona measures to decrease the transmission of the disease. Reflecting on the modifications to the environment provides an opportunity to design psychiatric environments for future pandemics or other demands for healthcare. The therapeutic environment of psychiatric wards was modified in Friesland, the Netherlands, in response to COVID-19. During this time, an interdisciplinary team met consistently to contribute to the preliminary design of a new psychiatric hospital. During the first 18 months of the pandemic, clinical reflections were made to describe the impact of COVID-19 on the psychiatric care environment. Architects have created a preliminary design of a new psychiatric hospital based on these reflections, monthly collaborative design discussions based on virtual mock-ups and evidence-based design based on theoretical concepts and research. This theoretical and reflective study describes how an inpatient psychiatric environment was restructured to manage infection during COVID-19. The therapeutic environment of the psychiatric ward and patient care changed drastically during COVID-19. The number of patients accessing care decreased, patient autonomy was restricted, and the function of designated behavioral support spaces changed to manage the risk of infection. However, these challenging times have provided an opportunity to reflect on theories and consider the design of new hospital environments that can be adapted in response to future pandemics or be restructured for different care functions.

Sections du résumé

OBJECTIVE
The COVID-19 pandemic has impacted healthcare systems worldwide. Although this disease has primarily impacted general medicine intensive care units, other areas of healthcare including psychiatry were modified in response to corona measures to decrease the transmission of the disease. Reflecting on the modifications to the environment provides an opportunity to design psychiatric environments for future pandemics or other demands for healthcare.
BACKGROUND
The therapeutic environment of psychiatric wards was modified in Friesland, the Netherlands, in response to COVID-19. During this time, an interdisciplinary team met consistently to contribute to the preliminary design of a new psychiatric hospital.
METHODS
During the first 18 months of the pandemic, clinical reflections were made to describe the impact of COVID-19 on the psychiatric care environment. Architects have created a preliminary design of a new psychiatric hospital based on these reflections, monthly collaborative design discussions based on virtual mock-ups and evidence-based design based on theoretical concepts and research.
RESULTS AND CONCLUSIONS
This theoretical and reflective study describes how an inpatient psychiatric environment was restructured to manage infection during COVID-19. The therapeutic environment of the psychiatric ward and patient care changed drastically during COVID-19. The number of patients accessing care decreased, patient autonomy was restricted, and the function of designated behavioral support spaces changed to manage the risk of infection. However, these challenging times have provided an opportunity to reflect on theories and consider the design of new hospital environments that can be adapted in response to future pandemics or be restructured for different care functions.

Identifiants

pubmed: 35549742
doi: 10.1177/19375867221098982
pmc: PMC9520130
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-368

Références

Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Psychiatry. 2020 Aug;7(8):e50
pubmed: 32711713
BMC Public Health. 2017 Jul 12;18(1):12
pubmed: 28697770
HERD. 2022 Apr;15(2):315-330
pubmed: 34847756
Am J Geriatr Psychiatry. 2020 Aug;28(8):829-834
pubmed: 32409192
Health Place. 2004 Jun;10(2):117-28
pubmed: 15019906
Sociol Health Illn. 2020 Feb;42(2):379-392
pubmed: 31657031
Ir J Psychol Med. 2020 Sep;37(3):181-186
pubmed: 32434599
Lancet Psychiatry. 2020 Oct;7(10):915-920
pubmed: 32171432
J Healthc Eng. 2019 Jan 6;2019:4076259
pubmed: 30723538
Issues Ment Health Nurs. 2021 Dec;42(12):1114-1122
pubmed: 34142934
SN Compr Clin Med. 2020;2(12):2546-2549
pubmed: 33140037
J Affect Disord. 2021 Mar 1;282:26-32
pubmed: 33387743
BMC Psychiatry. 2008 Dec 04;8:93
pubmed: 19055813
Community Ment Health J. 2021 Oct;57(7):1217-1226
pubmed: 34146189
Soc Sci Med. 2018 Jan;196:123-130
pubmed: 29175701
HERD. 2021 Jan;14(1):47-60
pubmed: 32539464
Psychosomatics. 2020 Nov - Dec;61(6):662-671
pubmed: 32800571
BMJ. 2011 Jul 26;343:d4163
pubmed: 21791490
J Med Ethics. 2020 Sep;46(9):579-580
pubmed: 32651254
Am J Geriatr Psychiatry. 2020 Aug;28(8):839-843
pubmed: 32565007
Int J Ment Health Syst. 2018 Oct 20;12:58
pubmed: 30377440
Ir J Psychol Med. 2020 Sep 11;:1-9
pubmed: 32912345
Rev Bras Enferm. 2020 Dec 21;73(suppl 5):e20200371
pubmed: 33338172
J Psychiatr Res. 2020 Dec;131:244-254
pubmed: 33035957
Int J Environ Res Public Health. 2021 Jul 29;18(15):
pubmed: 34360334
Psychodyn Psychiatry. 2020 Fall;48(3):234-258
pubmed: 32996853
Psychodyn Psychiatry. 2020 Winter;48(4):363-391
pubmed: 33779226
Br J Psychiatry. 2014 Sep;205(3):171-6
pubmed: 25179622
Aust N Z J Psychiatry. 2020 Jul;54(7):758
pubmed: 32363911
Front Psychiatry. 2020 Jun 11;11:550
pubmed: 32595541
HERD. 2020 Apr;13(2):83-102
pubmed: 31390887
Gen Hosp Psychiatry. 2016 Sep-Oct;42:15-21
pubmed: 27638966
Psychiatry Clin Neurosci. 2020 Oct;74(10):557-559
pubmed: 32609417
HERD. 2020 Apr;13(2):243-255
pubmed: 32000530
Health Place. 2012 Nov;18(6):1388-95
pubmed: 22853876
Curr Opin Psychiatry. 2008 Nov;21(6):593-7
pubmed: 18852567
Ir J Psychol Med. 2020 Sep;37(3):164-168
pubmed: 32434597
Community Ment Health J. 2021 Oct;57(7):1227-1229
pubmed: 34109512
BJPsych Open. 2020 Nov 12;6(6):e140
pubmed: 33176900
Soc Sci Med. 2013 Nov;97:201-9
pubmed: 23916450
Soc Sci Med. 1992 Apr;34(7):735-46
pubmed: 1376497
HERD. 2021 Jan;14(1):106-117
pubmed: 33205665
Soc Sci Med. 2007 Nov;65(9):1825-38
pubmed: 17706331
Community Ment Health J. 2021 Jan;57(1):10-17
pubmed: 32930903
Soc Sci Med. 2013 Nov;97:104-11
pubmed: 24161095
Health Place. 2015 May;33:83-9
pubmed: 25796009
Eur Psychiatry. 2019 Aug;60:49-62
pubmed: 31112827
Ir J Psychol Med. 2021 Jun;38(2):145-153
pubmed: 32434610
Psychiatr Q. 2022 Mar;93(1):181-197
pubmed: 34101075
BMJ Open. 2021 Jul 7;11(7):e046647
pubmed: 34233981
J Health Care Inter Des. 1991;3:97-109
pubmed: 10123973
HERD. 2022 Jul;15(3):315-328
pubmed: 35016562
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Health Place. 2014 Mar;26:94-9
pubmed: 24418525
Int J Psychiatry Clin Pract. 2021 Jun;25(2):135-139
pubmed: 33346685
J Clin Psychiatry. 2020 Sep 1;81(5):
pubmed: 32898342
BMJ Open. 2016 Jan 12;6(1):e010091
pubmed: 26758267
Health Place. 2014 Nov;30:287-92
pubmed: 25453749
J Med Internet Res. 2020 Oct 1;22(10):e22523
pubmed: 32936768

Auteurs

Jodi Sturge (J)

Adema Architecten, Groningen, the Netherlands.
Population Research Centre, University of Groningen, the Netherlands.

Ferdi Starrenburg (F)

GGZ Friesland, Leeuwarden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH